Trinity Biotech buys Bartels

Trinity Biotech has bought the Washington, US-based diagnostics manufacturer Bartels for $9.3 million (€10.41 million)

Trinity Biotech has bought the Washington, US-based diagnostics manufacturer Bartels for $9.3 million (€10.41 million). Founded in 1978, Bartels is a world leader in the development and manufacture of diagnostic products for the identification of infectious agents which are cell dependent.

  • Join The Irish Times on WhatsApp and stay up to date

  • Sign up to the Business Today newsletter for the latest new and commentary in your inbox

  • Listen to Inside Business podcast for a look at business and economics from an Irish perspective